Nanogenic Solutions Ltd

Nanogenic Solutions Ltd has developed a set of non-viral vectors that have shown outstanding transfection capabilities both in vitro (e.g. primary cell lines) and in-vivo (transfection of blood vessels and respiratory tract). Nanogenic is now selling its vector for lab reagent applications and has in-house therapeutic vector in development for cardiovascular indications. (This company replaces Genex Biosystems Ltd)

Year founded

2011

nanogenicsolutions.com